Financial Statements — BMI

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	89.22	87.17
Accounts Receivable	111.83	121.23	110.29	112.36	115.06	117.67	111.86	84.33	93.43	106.23	92.29	83.51	89.06	84.02	84.25	76.65	83.49	77.25	78.15	65.87
Inventory	166.43	178.09	175.19	151.94	152.63	147.26	149.41	143.41	158.52	161.27	160.44	153.67	147.79	144.75	132.34	119.86	113.61	111.44	103.02	99.61
Total Current Assets	367.90	416.21	508.30	507.08	494.59	448.28	411.58	540.12	529.30	509.22	470.60	442.18	422.95	388.59	360.84	347.83	325.63	303.92	281.28	261.36
Property, Plant & Equipment	83.47	83.44	80.83	79.64	78.36	77.94	75.69	74.26	73.28	72.45	72.93	73.88	74.44	74.71	74.53	73.54	72.37	74.04	76.07	78.05
Goodwill	302.81	302.61	234.65	235.58	236.65	235.70	231.54	111.77	115.00	113.36	113.47	113.16	112.70	113.80	113.77	101.26	99.10	101.21	103.29	104.31
Intangible Assets	157.51	162.54	114.40	118.50	122.06	126.11	131.09	45.07	48.96	50.18	52.47	53.74	54.63	57.51	59.51	53.61	54.31	57.77	61.25	64.18
Total Non-current Assets*	575.75	581.96	462.51	466.50	483.68	488.15	488.02	276.30	273.57	272.04	272.88	274.74	266.81	270.67	272.56	255.22	248.75	256.11	264.66	269.46
Total Assets	943.65	998.17	970.81	973.58	978.27	936.42	899.60	816.41	802.86	781.26	743.47	716.92	689.76	659.25	633.40	603.05	574.37	560.03	545.94	530.82
Accounts Payable	70.28	97.83	106.49	72.30	69.79	74.13	73.79	55.66	77.38	96.01	90.62	81.81	85.00	81.10	79.55	71.44	65.46	61.60	52.44	41.86
Short-term Debt	--	--	--	0.00	--	--	--	0.00	--	--	--	0.00	--	--	--	0.00	--	--	--	0.00
Total Current Liabilities	148.30	171.87	169.42	150.72	153.42	138.71	141.02	118.21	129.16	138.12	135.09	131.95	128.78	118.91	115.79	110.31	101.79	97.34	88.51	82.15
Total Non-current Liabilities*	144.22	143.42	110.96	109.57	122.34	120.12	116.89	91.98	82.51	80.00	72.81	68.49	68.27	64.75	59.58	50.31	49.73	46.51	47.55	45.60
Total Liabilities*	292.52	315.29	280.38	260.28	275.76	258.83	257.91	210.18	211.68	218.12	207.91	200.44	197.05	183.66	175.37	160.63	151.51	143.85	136.06	127.75
Retained Earnings	702.90	679.65	661.54	645.88	624.05	600.76	576.20	547.80	527.08	505.04	479.93	458.72	441.92	423.88	407.98	395.16	384.21	372.86	362.05	353.54
Total Stockholder Equity	651.13	682.88	690.43	713.29	702.51	677.59	641.69	606.23	591.18	563.14	535.57	516.48	492.71	475.59	458.04	442.42	422.86	416.18	409.88	403.07

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	235.94	222.32	202.28	220.71	695.96	238.10	222.21	205.18	208.44	216.66	196.28	182.44	186.19	175.86	159.10	147.32	148.01	137.83	132.40	135.75
Cost of Revenue	137.09	131.55	117.95	127.72	139.82	140.29	126.77	122.42	124.56	131.29	119.10	110.98	113.47	106.42	96.29	90.36	90.49	83.07	81.68	80.91
Gross Profit	98.85	90.77	84.33	92.99	95.84	97.81	95.44	82.76	83.88	85.37	77.18	71.47	72.72	69.43	62.82	56.97	57.52	54.76	50.72	54.84
Selling, General & Admin	51.11	51.40	49.16	49.94	49.75	52.95	46.01	43.54	43.26	43.86	40.60	39.39	41.30	39.93	37.77	34.49	33.65	32.67	31.86	31.98
Total Operating Expenses*	51.11	51.40	49.16	49.94	49.75	52.95	46.01	43.54	43.26	43.86	40.60	39.39	41.30	39.93	37.77	34.49	33.65	32.67	31.86	31.98
Operating Income	47.74	39.38	35.17	43.05	46.08	44.86	49.43	39.22	40.62	41.51	36.58	32.08	31.42	29.50	25.05	22.47	23.87	22.09	18.86	22.86
Pretax Income	47.96	39.72	36.34	44.64	47.44	45.79	50.79	42.14	42.91	43.36	38.09	33.44	32.59	30.30	25.64	22.91	23.95	22.05	18.82	22.88
Tax Provision	12.06	10.00	9.00	11.07	12.37	11.20	12.39	11.42	10.87	10.31	8.96	8.72	6.62	7.80	6.22	5.37	6.01	5.38	4.46	5.60
Net Income	35.90	29.72	27.34	33.58	35.08	34.58	38.40	30.72	32.04	33.06	29.13	24.72	25.97	22.49	19.42	17.54	17.93	16.66	14.36	17.28
Basic EPS	1.25	1.02	0.94	1.14	1.19	1.18	1.31	1.05	1.09	1.13	0.99	0.84	0.89	0.77	0.66	0.61	0.61	0.57	0.49	0.60
Diluted EPS	1.24	1.02	0.93	1.13	1.19	1.17	1.30	1.04	1.08	1.12	0.99	0.84	0.88	0.76	0.66	0.59	0.61	0.57	0.49	0.59

← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	43.27	26.71	33.89	54.80	51.28	44.59	33.03	52.07	45.09	36.42	21.46	37.95	31.43	22.77	17.97	29.71	23.83	19.66	9.25	24.75
Capital Expenditures	2.99	4.84	4.43	4.03	3.09	3.94	2.97	4.67	3.13	2.34	2.68	2.05	3.01	2.66	4.27	1.20	1.92	1.63	1.14	(1.42)
Free Cash Flow*	40.28	21.87	29.47	50.77	48.20	40.65	30.06	47.40	41.96	34.08	18.78	35.89	28.42	20.11	13.70	28.51	21.91	18.03	8.11	26.17
Investing Cash Flow	(2.54)	(99.21)	(4.43)	(4.03)	(3.09)	(3.02)	(187.90)	(4.67)	(3.13)	(2.34)	(5.68)	(2.05)	(3.01)	(2.74)	(21.32)	(1.20)	(1.92)	(1.63)	(1.14)	1.42
Financing Cash Flow	(68.18)	(36.85)	(49.78)	(26.74)	(11.77)	(9.52)	(9.95)	(9.98)	(9.99)	(7.41)	(7.71)	(7.92)	(7.01)	(6.59)	(6.57)	(5.95)	(6.52)	(6.27)	(5.87)	(5.84)

← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Dividends Per Share	0.44	0.40	0.40	0.40	0.40	0.34	0.34	0.34	0.34	0.27	0.27	0.26	0.27	0.23	0.23	0.22	0.23	0.20	0.20	0.20

← Scroll for more columns →